Mr. Graeme Duncan reports

ADVANZ PHARMA CORP. ANNOUNCES RELEASE DATE FOR FOURTH QUARTER AND 2018 RESULTS

Advanz Pharma Corp. intends to release its fourth quarter and 2018 financial results before market open on Thursday, March 14, 2019.

The company will subsequently hold a conference call that same day, Thursday, March 14, 2019, at 8:30 a.m. ET, hosted by Graeme Duncan, chief executive officer, and other senior management. A question-and-answer session will follow the corporate update.

Conference call details

Date:   Thursday, March 14, 2019

Time:  8:30 a.m. ET

Dial-in numbers:   647-427-7450 or 888-231-8191

Taped replay:   416-849-0833 or 855-859-2056

Reference No.:  1698824

About Advanz Pharma Corp.

Advanz Pharma is an international specialty pharmaceutical company with a diversified portfolio of more than 200 patented and off-patent products and sales in more than 90 countries. Going forward, the company is focused on becoming the leading platform for niche established medicines, with advanced commercial capabilities throughout western Europe.

Advanz Pharma operates out of facilities in Mississauga, Ont., and, through its subsidiaries, operates out of facilities in Bridgetown, Barbados; London, England; and Mumbai, India.

We seek Safe Harbor.